Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
Lilly touts winning tirzepatide data in prediabetes patients
Lilly on Wednesday laid out full results from its longest completed study of the dual GIP/GLP-1 receptor agonist tirzepatide to date.
Fraiser Kansteiner
Nov 13, 2024 5:01pm
Novo Nordisk's semaglutide delivers in phase 3 MASH study
Nov 1, 2024 10:38am
BMS partner Zai Lab eyes China filing for KarXT after trial win
Oct 29, 2024 1:59pm
EyePoint's Duravyu bounces back with promising DME data
Oct 28, 2024 1:11pm
Novartis, Apellis roll out rival datasets in rare kidney disease
Oct 28, 2024 10:03am
GSK rolls out positive 3-year data on RSV vaccine Arexvy
Oct 8, 2024 11:29am
